Abstract

Abstract Toll-like receptors (TLRs) are pattern recognition receptors that bridge the innate and adaptive immune system and are critical for host defense. TLR signaling to B cells is important in normal immunity, but also implicated in autoimmune disease and B cell lymphomas (BCL). Most studies focus on the role of TLRs in myeloid cell populations. However, B cells express most TLRs and are highly responsive to TLR ligands, yet TLR-mediated B cell pathways are understudied. Previous studies from our lab show that TRAF3 inhibits B cell TLR functions, including cytokine production, Ig isotype switching, and antibody production in response to ligands for TLRs 3, 4, 7/8 and 9. A key knowledge gapis identifying the molecular mechanisms by which TRAF3 mediates this regulation. Our working hypothesisis that B cell-TRAF3 regulates the recruitment and/or post-translational modification of specific TLR complex signaling proteins. Our recent data show that B cell-TRAF3 forms a heterocomplex with TRAF6, associating with the tyrosine kinase Syk. In the absence of TRAF3, TRAF6 shows a greater association with several TLR signaling proteins, including MyD88, IRAK1 and Syk. This suggests that TRAF3 may inhibit TRAF6 access to the TLR signaling complex, and thus early TLR signaling. In addition, our work introduces a role for Syk in TLR signaling in B cells. In the absence of TRAF3, activation of Syk is enhanced in response to ligands for TLRs 4 and 7. Inhibition of Syk activation also revealed downstream effects on TLR-mediated NFκB activation. Further studies aim at providing new insights into molecular mechanisms contributing to the regulation of B cell-TRAF3 in TLR signaling. VA Merit Review I01 BX001702 NIH P50 CA97274 RO1 AI5107312000000113259002001 NIH T32 Training Grant AI07485 RO1 AI1762656

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call